Treatmybrand


a Kainjoo SA Venture
Ch. du Vernay 14a
1196 Gland
+41.21.561.34.96
info@treatmybrand.com

Support


Monday to Friday
8AM to 8PM
support@treatmybrand.com
Back

Why U.S. Companies Are Rethinking Their Health Insurance Options

Why U.S. Companies Are Rethinking Their Health Insurance Options
  • Inc.
  • Posted by Inc.
April 23, 2026

Why U.S. Companies Are Rethinking Their Health Insurance Options

U.S. employers face increasing health insurance premiums and new transparency rules, prompting a shift toward more cost-effective, nontraditional insurers and pharmacy benefit managers to manage expenses.

Read More
Google's Gemini AI Now Operates Securely on a Single Air-Gapped Server with Complete Data Privacy
  • Venturebeat
  • Posted by Venturebeat
April 23, 2026

Google's Gemini AI Now Operates Securely on a Single Air-Gapped Server with Complete Data Privacy

Cirrascale and Google Cloud have introduced a secure, air-gapped Gemini AI appliance that runs locally on dedicated hardware, ensuring total data privacy by erasing the model when powered off. This solution caters to industries needing high security, like finance and healthcare, enabling use of Google's advanced model without sacrificing control or compliance. It represents a shift toward private AI deployments outside public clouds.

Read More
Assessing the Reliability of AI Chatbots for Medical Guidance
  • Silicon Republic
  • Posted by Silicon Republic
April 22, 2026

Assessing the Reliability of AI Chatbots for Medical Guidance

Carsten Eickhoff of the University of Tübingen investigates the limitations and issues faced when using AI chatbots to provide medical advice, emphasizing the need for caution in relying on these tools in healthcare contexts.

Read More
Groundbreaking mRNA Vaccine Offers Tailored Cancer Treatment
  • Inc.
  • Posted by Inc.
April 22, 2026

Groundbreaking mRNA Vaccine Offers Tailored Cancer Treatment

Recent advances reveal that mRNA-based cancer vaccines could revolutionize treatment by providing highly personalized therapies, adapting uniquely to individual patient needs and potentially improving outcomes significantly.

Read More
The Illusion of AI Governance: Why 72% of Enterprises Overestimate Their Control and Security
  • Venturebeat
  • Posted by Venturebeat
April 22, 2026

The Illusion of AI Governance: Why 72% of Enterprises Overestimate Their Control and Security

A recent survey reveals that 72% of enterprises rely on multiple AI platforms, often without coordinated governance, leading to security gaps and operational complexity. While confidence in AI oversight is high, many lack clear accountability and systematic controls. Experts advocate for unified control solutions to manage risks and prevent vendor lock-in, emphasizing the need for independent governance to truly secure AI deployments.

Read More
Transforming Front Desks: The Rise of AI Receptionists Across Industries
  • borndigital
  • Posted by borndigital
April 22, 2026

Transforming Front Desks: The Rise of AI Receptionists Across Industries

AI receptionists are revolutionizing front desk operations by offering 24/7 handling of calls, visitor management, and administrative tasks through voice and digital human interfaces. By integrating deeply with business systems, they reduce costs, lower no-shows by 30%, accelerate check-ins, and improve visitor experiences across healthcare, corporate offices, and hospitality, providing a scalable, efficient alternative to traditional receptionists.

Read More
Eli Lilly Acquires Gene Therapy Innovator Kelonia Therapeutics in Landmark $7 Billion Deal
  • Crunchbase
  • Posted by Crunchbase
April 21, 2026

Eli Lilly Acquires Gene Therapy Innovator Kelonia Therapeutics in Landmark $7 Billion Deal

Eli Lilly has acquired Kelonia Therapeutics in a $7 billion cash deal, marking the largest acquisition of a venture-backed biotech in years. Kelonia, known for its promising gene therapies targeting cancer, offers innovative treatments that reprogram patients' T-cells inside the body. This acquisition reflects increasing investment in gene therapy startups focused on faster, more effective cancer treatments.

Read More
Coral Secures $12.5 Million to Streamline Healthcare Admin with AI
  • The Next Web
  • Posted by The Next Web
April 21, 2026

Coral Secures $12.5 Million to Streamline Healthcare Admin with AI

Coral, a New York startup, has raised $12.5M to automate healthcare administrative tasks using AI that reads handwritten faxes and processes patient intakes quickly without disrupting provider routines. The company has already achieved significant revenue milestones and targets a 4x growth by 2026.

Read More
AIM Centre Expands Westward with New Galway Hub to Boost Medtech and Life Sciences
  • Silicon Republic
  • Posted by Silicon Republic
April 21, 2026

AIM Centre Expands Westward with New Galway Hub to Boost Medtech and Life Sciences

AIM Centre is growing beyond Sligo to establish a Galway hub, enhancing its connection with medtech and life sciences sectors in western Ireland to foster industry collaboration and innovation.

Read More
ONWARD Medical Secures €40.6M to Propel Spinal Cord Stimulation Implant Development
  • The Next Web
  • Posted by The Next Web
April 18, 2026

ONWARD Medical Secures €40.6M to Propel Spinal Cord Stimulation Implant Development

ONWARD Medical has raised €40.6 million to advance clinical trials and commercial efforts for its spinal cord stimulation technologies, focusing on treating blood pressure instability after spinal cord injuries and scaling its external therapy systems. This funding boosts the company's runway to early 2028.

Read More
OpenAI Launches AI Model to Compete with Google's AlphaFold in Life Sciences
  • Silicon Republic
  • Posted by Silicon Republic
April 18, 2026

OpenAI Launches AI Model to Compete with Google's AlphaFold in Life Sciences

OpenAI unveils its inaugural Life Science model, set to rival Google's AlphaFold, with the goal of accelerating research and innovation in biology and healthcare.

Read More
AI and Healthcare: Bridging the Gap Between Hype and Human Impact
  • Fast Company
  • Posted by Fast Company
April 18, 2026

AI and Healthcare: Bridging the Gap Between Hype and Human Impact

AI companies promise much in healthcare, but real success requires proven impact in humans through rigorous trials. Leading firms close the gap by testing AI-driven treatments in clinical settings and refining models with patient data, creating a continuous feedback loop that enhances outcomes and bridges hype with reality.

Read More
AI Revolutionizing Personalized Education and Decision-Making in Aesthetics
  • Fast Company
  • Posted by Fast Company
April 18, 2026

AI Revolutionizing Personalized Education and Decision-Making in Aesthetics

AI is transforming the aesthetics industry by enabling personalized, data-driven consultations that align patient expectations with realistic treatment outcomes. By integrating AI skin analysis and visualization tools, practitioners enhance patient education, build trust, increase satisfaction, and drive business growth. The democratization of these AI technologies is making advanced personalized skincare accessible beyond luxury clinics, signaling a major shift in how consumers engage with aesthetic treatments.

Read More
Cambridge Biotech STORM Therapeutics Secures $56M to Advance RNA Enzyme Inhibitor for Cancer Treatment
  • The Next Web
  • Posted by The Next Web
April 17, 2026

Cambridge Biotech STORM Therapeutics Secures $56M to Advance RNA Enzyme Inhibitor for Cancer Treatment

STORM Therapeutics raised $56 million to further develop STC-15, an innovative RNA enzyme inhibitor showing promising results in early cancer trials. The funding round was backed by existing investors Pfizer Ventures and M Ventures, highlighting strong confidence in the company's approach to targeting RNA modifications for cancer treatment.

Read More
OpenAI Launches GPT-Rosalind: A Specialized AI Model Transforming Life Sciences Research
  • Venturebeat
  • Posted by Venturebeat
April 17, 2026

OpenAI Launches GPT-Rosalind: A Specialized AI Model Transforming Life Sciences Research

OpenAI introduces GPT-Rosalind, a specialized AI model designed to transform life sciences research by accelerating experiment planning and data integration. With domain-specific expertise, it outperforms prior models in bioinformatics tasks and is complemented by a new Codex plugin connecting researchers to extensive biological databases. Currently accessible only to qualified US enterprises, GPT-Rosalind is poised to accelerate drug discovery and reduce research costs, earning strong support from major industry players.

Read More
Florence Nightingale: A Trailblazer in Healthcare Innovation
  • MIT Review
  • Posted by MIT Review
April 17, 2026

Florence Nightingale: A Trailblazer in Healthcare Innovation

Florence Nightingale revolutionized healthcare by combining compelling data communication, clear caregiving guidance, and standardized nursing education. Beyond her compassionate image, she used innovative strategies to fight disease, improve hospital conditions during the Crimean War, and professionalize nursing. Her legacy offers enduring lessons in effective disruption without needing advanced technology or larger-than-life leadership, highlighting how persistence and collaboration can drive transformational change.

Read More
healthcare ai startup
  • Crunchbase
  • Posted by Crunchbase
April 16, 2026

Why I Sold My Healthcare AI Startup Within a Year to Accelerate Real-World Impact

Louis Blankemeier shares why selling his healthcare AI startup within a year enabled faster progress in developing clinically reliable radiology AI. Joining forces with Radiology Partners provided the scale, data, and clinical resources needed to navigate complex regulatory and real-world challenges, thereby accelerating the mission to expand healthcare access globally.

Read More
Helical Secures $10M Seed Funding to Advance Bio Foundation Models for Pharma
  • The Next Web
  • Posted by The Next Web
April 15, 2026

Helical Secures $10M Seed Funding to Advance Bio Foundation Models for Pharma

London-based pharma AI startup Helical raised $10M in seed funding led by redalpine and backed by key industry figures. The company collaborates with top pharmaceutical firms like Pfizer to develop bio foundation models into operational systems.

Read More
Google.org and Johnson & Johnson Foundation Launch $10M Program to Train Rural U.S. Healthcare Workers in AI
  • google
  • Posted by google
April 15, 2026

Google.org and Johnson & Johnson Foundation Launch $10M Program to Train Rural U.S. Healthcare Workers in AI

Google.org and Johnson & Johnson Foundation have introduced a $10 million initiative to train rural U.S. healthcare workers in AI, providing grants to clinics to improve healthcare operations with advanced technology.

Read More
Ireland to Channel €17 Million into Cutting-Edge AI, Medtech, and Advanced Tech Facilities
  • Silicon Republic
  • Posted by Silicon Republic
April 15, 2026

Ireland to Channel €17 Million into Cutting-Edge AI, Medtech, and Advanced Tech Facilities

Ireland is investing €17 million to develop advanced facilities that will support innovation in AI, medical technology, semiconductors, and other high-tech fields, positioning the country as a hub for next-generation technological advancements.

Read More